
Shenzhen Bioeasy Biotechnology Co., Ltd. — Investor Relations & Filings
Shenzhen Bioeasy Biotechnology Co., Ltd. specializes in the development, production, and marketing of rapid testing solutions for food safety, clinical diagnosis, and animal health. The company provides a comprehensive portfolio of diagnostic products, including rapid test strips, enzyme-linked immunosorbent assay (ELISA) kits, and automated detection instruments. Its core focus areas include the detection of antibiotic residues, mycotoxins, pesticides, and foodborne pathogens in dairy, meat, seafood, and grain products. In the clinical sector, Bioeasy offers point-of-care testing (POCT) solutions for infectious diseases and chronic conditions. The company emphasizes research and development to deliver high-sensitivity, user-friendly diagnostic tools that meet international quality standards. Its products are utilized by food producers, regulatory agencies, and healthcare providers to ensure safety and quality control across the global supply chain.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 关于控股股东及其一致行动人减持计划期限届满暨减持结果的公告 | 2026-02-02 | Chinese | |
| 关于实际控制人部分股份解除质押及再质押的公告 | 2026-02-02 | Chinese | |
| 关于控股股东部分股份解除质押的公告 | 2026-01-13 | Chinese | |
| 关于控股股东及其一致行动人权益变动触及1%整数倍的提示性公告 | 2026-01-06 | Chinese | |
| 关于2025年第四季度可转债转股情况的公告 | 2026-01-05 | Chinese | |
| 关于控股股东及其一致行动人权益变动触及1%整数倍的提示性公告 | 2025-12-04 | Chinese |
Browse filings by year
6 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
5 filings
| |||||
| 39196786 | 关于控股股东及其一致行动人减持计划期限届满暨减持结果的公告 | 2026-02-02 | Chinese | ||
| 39196778 | 关于实际控制人部分股份解除质押及再质押的公告 | 2026-02-02 | Chinese | ||
| 39196767 | 关于控股股东部分股份解除质押的公告 | 2026-01-13 | Chinese | ||
| 39196764 | 关于控股股东及其一致行动人权益变动触及1%整数倍的提示性公告 | 2026-01-06 | Chinese | ||
| 39196749 | 关于2025年第四季度可转债转股情况的公告 | 2026-01-05 | Chinese | ||
|
2025
10 filings
| |||||
| 39196737 | 关于控股股东及其一致行动人权益变动触及1%整数倍的提示性公告 | 2025-12-04 | Chinese | ||
| 39196726 | 关于募集资金专项账户全部注销完成的公告 | 2025-11-14 | Chinese | ||
| 39196712 | 关于参加2025年度深圳辖区上市公司投资者网上集体接待日活动的公告 | 2025-11-14 | Chinese | ||
| 39196702 | 2025年三季度报告 | 2025-10-27 | Chinese | ||
| 39196690 | 关于补选第三届董事会战略委员会委员的公告 | 2025-10-27 | Chinese | ||
| 39196679 | 第三届董事会第十四次会议决议公告 | 2025-10-27 | Chinese | ||
| 39196669 | 关于更换持续督导保荐代表人的公告 | 2025-10-15 | Chinese | ||
| 39196661 | 关于控股股东及其一致行动人减持股份的预披露公告 | 2025-10-12 | Chinese | ||
| 39196653 | 关于全资子公司出售资产的进展公告 | 2025-10-09 | Chinese | ||
| 39196646 | 关于2025年第三季度可转债转股情况的公告 | 2025-10-09 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Shenzhen Bioeasy Biotechnology Co., Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/55906/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=55906 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=55906 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=55906 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 55906}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Shenzhen Bioeasy Biotechnology Co., Ltd. (id: 55906)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.